Treatment of multiple sclerosis
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2003, Vol 20, Issue 5
Abstract
Multiple sclerosis (MS) is an autoimmune disease. The therapeutic approach to MS is threefold: (a) Management of acute exarcebations, (b) prophylactic treatment which attempts to modify the immunologic basis of the disease, (c) alleviation of everyday symptoms. Acute exarcebations of MS are managed with a 3–5 day course of intravenous methylprednisolone or ACTH analogue followed by tapering doses of oral steroids over a period of one month. Prophylactic treatment includes specific immuno-modulatory/-suppressive medications (i.e. interferon â-1b, interferon â-1a, intravenous immunoglobulin, cyclosporine), non-specific immunuo-modulatory/- suppressive medications (i.e. azathioprine, cyclophosphamide, mitoxandrone, methotrexate), drugs that activate physiologic feedback loops (Cop-1/Copaxone) and a variety of other treatments which are difficult to categorize. Symptomatic treatment is targeted at everyday symptoms, such as tiredness, spasticity, chronic pain and tremor of the extremities. Although the definitive treatment of MS remains elusive, modern basic and clinical research offers an optimistic outlook.
Authors and Affiliations
N. TRIANTAFYLLOU
Keywords
Related Articles
- EP ID EP139209
- DOI -
- Views 87
- Downloads 0
The hepatopulmonary syndrome: Current trends
Lung complications may occur as a result of hepatic disease from any cause and they represent a highly heterogeneous group of conditions. The hepatopulmonary syndrome (HPS) is characterized as the triad of liver disease,...
Co-administration of vasopressin-levosimendan improves survival in a swine model of ventricular fibrillation
OBJECTIVE It was hypothesized that the co-administration of vasopressin and levosimendan during cardiopulmonary resuscitation would improve survival and neurological outcome in comparison to the administration of vasopre...
Στατιστικοί έλεγχοι της εγκυρότητας και της αξιοπιστίας του Ελληνικού SF-36<br />
Comparison of costs of hemoglobin A1c determination by point-of-care testing (POCT) and standard hemoglobin A1c analyzer
OBJECTIVE The use of the levels of hemoglobin A1c for the monitoring of glycemic control in patients with diabetes mellitus (DM) is an accepted method of clinical usefulness. A study was performed to assess the relative...
Θεραπευτικά διλήμματα επί σοβαρής θρομβοεμβολικής νόσου από έλλειψη πρωτεΐνης C<br />